CARRIE GWYER: Open Payments
NPI 1467837369 · MURRELLS INLET, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,549 in 75 payments from 17 companies in 2025. Trend: 2023 $896 · 2024 $1,010 · 2025 $1,549
Food & beverage: $1,450Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $394 |
| Janssen Biotech, Inc. | 12 | $318 |
| Novo Nordisk Inc | 3 | $179 |
| GENZYME CORPORATION | 6 | $155 |
| Ardelyx, Inc. | 9 | $145 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $78 |
| Madrigal Pharmaceuticals | 2 | $46 |
| Regeneron Healthcare Solutions, Inc. | 1 | $40 |
| QOL Medical, LLC | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $29 |
Products named: TREMFYA, DUPIXENT, Wegovy, SKYRIZI, IBSRELA, MAVYRET, CREON, XIFAXAN.
Industry payments across SC — which companies pay providers there.
